Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × olaparib × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Ovarian Neoplasms 13 Fallopian Tube Neoplasms 8 Triple Negative Breast Neoplasms 7 Pancreatic Neoplasms 7 Neoplasms 7 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Endometrial Neoplasms 4 Neuroendocrine Tumors 3 Carcinoma, Ovarian Epithelial 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Cholangiocarcinoma 2 Advanced Solid Tumor 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Platinum-sensitive Ovarian Cancer 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 20 Temozolomide 12 pembrolizumab 10 Bevacizumab 9 Specimen Handling 8 Radiotherapy 6 Nivolumab 6 Ipilimumab 6 Magnetic Resonance Imaging 5 Cyclophosphamide 5 Capecitabine 5 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 fluoromisonidazole 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711824 2025-12-23

SOLARA

Hoosier Cancer Research Network

Phase 1/2 Recruiting

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡